Evidence map›Paper›PMID 42802841›Full record

ArticleCureus2026

Preliminary Cellular and Contamination-Related Observations From Adinizer-Processed Microfragmented Adipose Tissue: A Technical Note on Three Donors.

Yonghyun Yoon, Jihyo Hwang, Jungyoun Kim, Teinny Suryadi, Anwar Suhaimi, Jeimylo C de Castro, King Hei Stanley Lam

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yonghyun YoonOrthopedics, International Academy of Musculoskeletal Medicine, Hong Kong, HKG.
Jihyo HwangOrthopedic Surgery, Hallym University Kangnam Sacred Heart Hospital, Seoul, KOR.
Jungyoun KimOrthopedic Surgery, Hallym University Kangnam Sacred Heart Hospital, Seoul, KOR.
Teinny SuryadiPhysical Medicine and Rehabilitation, Medistra Hospital, Jakarta, IDN.
Anwar SuhaimiRehabilitation Medicine, University Malaya Medical Centre, Kuala Lumpur, MYS.
Jeimylo C de CastroResearch, Adventist University of the Philippines, Cavite, PHL.
King Hei Stanley LamClinical Research, International Academy of Regenerative Medicine, Incheon, KOR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Microfragmented adipose tissue (MFAT) is a mechanically processed adipose-tissue preparation that retains extracellular matrix and heterogeneous stromal and immune cell populations. Because intact MFAT is not a single-cell suspension, cellular enumeration requires laboratory dissociation. This retrospective technical note describes preliminary cellular observations and limited contamination screening results in Adinizer-processed MFAT from three donors. Methods De-identified laboratory records from three female donors were retrospectively reviewed with institutional review board approval and written informed consent. Residual lipoaspirate was mechanically processed using serial Adinizer cutting units (2400, 1200, 600, and 400 μm; five passes at each size), centrifuged at 1,200 × g for 5 minutes, cleared of the upper oil-containing layer, and passed through a final 200-μm cutting unit. A 3-mL aliquot of refined MFAT was enzymatically dissociated. Cell concentration and viability were measured in duplicate as technical replicates and averaged. Cells were stained for CD34, CD45, CD90, and CD146. Mycoplasma and endotoxin findings were reviewed as limited contamination screening results. Results Donor ages ranged from 43 to 70 years and BMI from 34.5 to 39.9 kg/m². Mean recovered cell concentrations ranged from 1.41 × 10⁵ to 8.41 × 10⁵ cells/mL, corresponding to 2.82 × 10⁵ to 1.68 × 10⁶ total recovered cells from each 3-mL aliquot. Mean viability ranged from 65.8% to 78.6%, with calculated viable recovered cell counts of 2.11 × 10⁵ to 1.32 × 10⁶. Laboratory-reported ASC-like fractions ranged from 15.4% to 24.4%, and leukocyte fractions from 22.6% to 32.0%. Mycoplasma testing was negative in all samples, and all endotoxin results met the laboratory acceptance criterion of <1 EU/mL. Conclusions Viable cells, including a laboratory-defined ASC-like fraction, were recovered after enzymatic liberation of Adinizer-processed MFAT. Recovered cell yield varied substantially among donors, with no consistent monotonic pattern across the obese BMI range represented. The ASC-like fraction suggests preservation of a stromal/progenitor-compatible cellular component after mechanical processing; however, the limited marker panel and absence of functional assays preclude conclusions regarding definitive mesenchymal stromal/stem-cell identity or functional stemness. Mycoplasma and endotoxin findings should be interpreted only as limited contamination screening results, not as evidence of sterility or product safety. Larger prospective studies with complete flow-cytometric documentation, broader marker panels, and functional assays are required.

Indexed as

adinizeradipose-derived stromal cellscell viabilityendotoxinflow cytometrymicrofragmented adipose tissuemycoplasmaregenerative medicine

Identifiers

PMID42802841
PMCPMC13616441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.